However, laboratory findings of early phase of COVID-19 show a moderate decrease in platelet counts, mild prolongation of prothrombin time, and high fibrinogen levels, which are different from DIC, and leads us to consider other pathomechanisms of COVID-19 coagulopathy (11). The gene discussed is F2; the disease is blood coagulation disease.